ATE214708T1 - Kationische mittel zur transfektion von nukleinsäuren - Google Patents

Kationische mittel zur transfektion von nukleinsäuren

Info

Publication number
ATE214708T1
ATE214708T1 AT98928418T AT98928418T ATE214708T1 AT E214708 T1 ATE214708 T1 AT E214708T1 AT 98928418 T AT98928418 T AT 98928418T AT 98928418 T AT98928418 T AT 98928418T AT E214708 T1 ATE214708 T1 AT E214708T1
Authority
AT
Austria
Prior art keywords
transfection
nucleic acids
cationic agents
cationic
transfecting agents
Prior art date
Application number
AT98928418T
Other languages
English (en)
Inventor
Michel Bessodes
Daniel Scherman
Jean Herscovici
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE214708T1 publication Critical patent/ATE214708T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98928418T 1997-06-06 1998-06-03 Kationische mittel zur transfektion von nukleinsäuren ATE214708T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707014A FR2764304B1 (fr) 1997-06-06 1997-06-06 Nouvelle classe d'agents transfectants cationiques des acides nucleiques
PCT/FR1998/001112 WO1998055490A1 (fr) 1997-06-06 1998-06-03 Nouvelle classe d'agents transfectants cationiques des acides nucleiques

Publications (1)

Publication Number Publication Date
ATE214708T1 true ATE214708T1 (de) 2002-04-15

Family

ID=9507684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928418T ATE214708T1 (de) 1997-06-06 1998-06-03 Kationische mittel zur transfektion von nukleinsäuren

Country Status (18)

Country Link
EP (1) EP0986568B1 (de)
JP (1) JP2002504815A (de)
KR (1) KR20010013312A (de)
CN (1) CN1259134A (de)
AT (1) ATE214708T1 (de)
AU (1) AU737579B2 (de)
BR (1) BR9809953A (de)
CA (1) CA2292837A1 (de)
DE (1) DE69804302T2 (de)
DK (1) DK0986568T3 (de)
ES (1) ES2174445T3 (de)
FR (1) FR2764304B1 (de)
HU (1) HUP0004577A3 (de)
NO (1) NO314147B1 (de)
PL (1) PL337177A1 (de)
PT (1) PT986568E (de)
WO (1) WO1998055490A1 (de)
ZA (1) ZA984845B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015465A2 (de) * 1997-09-08 2000-07-05 Valentis Inc. Hydrophobes glycosylamine-derivative, zusammensetzungen und verfahren zur verwendung
DE19942864A1 (de) * 1999-09-08 2001-03-15 Knoell Hans Forschung Ev Neue O-(Aminoalkyl)-Derivate von Monosacchariden, Verfahren zu ihrer Herstellung und ihre Verwendung als antibakterielle Mittel
JP4629333B2 (ja) * 2001-08-29 2011-02-09 アベンティス・ファーマ・ソシエテ・アノニム アミノグリコシドの脂質誘導体
FR2829136B1 (fr) * 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
PL2027137T3 (pl) 2005-06-08 2015-08-31 Amicus Therapeutics Inc Oczyszczanie imino- i aminocukrów
WO2008081686A1 (ja) * 2006-12-28 2008-07-10 Konica Minolta Holdings, Inc. コレステロール誘導体、リポソーム、リポソームの形成方法およびｘ線用造影剤
WO2017151733A1 (en) * 2016-03-01 2017-09-08 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
AU2019271215B2 (en) * 2018-05-16 2024-09-12 Translate Bio, Inc. Ribose cationic lipids
EP3841123A2 (de) 2018-08-23 2021-06-30 Seagen Inc. Anti-tigit-antikörper

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774417B2 (ja) * 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
DE4329093A1 (de) * 1993-08-30 1995-03-02 Bayer Ag Substituierte Aminoalkylglycoside
AU4923696A (en) * 1995-02-10 1996-08-27 Nexstar Pharmaceuticals, Inc. Lipid constructs for cytoplasmic delivery of agents

Also Published As

Publication number Publication date
NO995858D0 (no) 1999-11-30
WO1998055490A1 (fr) 1998-12-10
JP2002504815A (ja) 2002-02-12
NO995858L (no) 1999-11-30
BR9809953A (pt) 2000-08-01
ZA984845B (en) 1998-12-29
DE69804302T2 (de) 2002-10-17
FR2764304B1 (fr) 1999-07-16
CN1259134A (zh) 2000-07-05
DK0986568T3 (da) 2002-06-10
NO314147B1 (no) 2003-02-03
ES2174445T3 (es) 2002-11-01
AU8025098A (en) 1998-12-21
EP0986568A1 (de) 2000-03-22
EP0986568B1 (de) 2002-03-20
PT986568E (pt) 2002-08-30
PL337177A1 (en) 2000-08-14
FR2764304A1 (fr) 1998-12-11
HUP0004577A1 (hu) 2001-04-28
KR20010013312A (ko) 2001-02-26
CA2292837A1 (fr) 1998-12-10
DE69804302D1 (de) 2002-04-25
AU737579B2 (en) 2001-08-23
HUP0004577A3 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
PT983087E (pt) Composicao de vacina multivalente com veiculo misto
DE69840748D1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
DE69628864D1 (de) Invertierte chimäre und hybrid-oligonukleotide
ATE394484T1 (de) Smad 6 und dessen anwendungen
DE69730218D1 (de) Fusogene liposomen
EP1248794A4 (de) Antisens-modulierung der smad7 expression
EP0881914A4 (de)
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
DK0817851T5 (da) DNA, der koder for humant papillomvirus type 18
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
BR9811592A (pt) Oxidase de citocinina
DE69804302D1 (de) Kationische mittel zur transfektion von nukleinsäuren
DE69009913D1 (de) Kationische Elektrotauchlackierzusammensetzung.
IT1270618B (it) Proteine ad attivita' antitumorale
ATE348158T1 (de) Neuartiges collectin
EP1165145A4 (de) Antisense-modulation der mdmx-expression
ES2065472T3 (es) Composiciones de betun.
BR9811579B1 (pt) ácidos 3-ciano-2,4-dialógeno-5-fluorobenzóicos e processo para a preparação dos mesmos.
EP1118659A4 (de) Expressionssysteme zur funktionellen expression von nukleinsäuren
NO964894L (no) Rekombinante viruser, deres fremstilling samt anvendelse av genterapi
ES555466A0 (es) Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee